Is CDAK a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Codiak BioSciences, Inc. (CDAK) is (9.05) USD. With the latest stock price at 0.06 USD, the upside of Codiak BioSciences, Inc. based on DCF is -15980.7%. This means that CDAK is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 10.1% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (27.15) - (5.61) | (9.05) |
| Upside | -47724.9% - -9945.9% | -15980.7% |